Sort
15,842 grants matching “pancreatic cancer”
Optimization of High Frequency Irreversible Electroporation (H-FIRE) for tumor ablation and immune system activation in pancreatic cancer applications
$528,946Irving C Allen · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · CA
Role of RABL6A-PP2A in neuroendocrine tumors
$528,258Dawn E Quelle · University Of Iowa · R01 · FY2023 · CA
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
$528,058William C Zamboni · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
$527,973Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · U01 · FY2021 · CA
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
$527,973Howard C Crawford · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
Lysyl Oxidase Propeptide: Breast Cancer Inhibitor
$527,955Gail E Sonenshein · Tufts University Boston · R01 · FY2010 · CA
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
$527,544Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2022 · CA
Targeting Lymph Node Dependent Immune Tolerance in Cancer
$527,382Edgar G. Engleman · Stanford University · R01 · FY2023 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$527,354Albert Folch · University Of Washington · R01 · FY2023 · CA
Novel Targeted Anticancer Agents from Marine Cyanobacteria
$527,273Hendrik Luesch · University Of Florida · R01 · FY2025 · CA
The Role of TGFβ2 and Macrophages in Cancer Cachexia
$527,199Kandy T Velazquez · University Of South Carolina At Columbia · R01 · FY2025 · CA
Early Diagnosis of Pancreatic Cancer
$527,186University Of Nebraska Medical Center · U01 · FY2004 · CA
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
$526,941Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2022 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$526,891Albert Folch · University Of Washington · R01 · FY2022 · CA
Ultrasound enhanced penetration for treatment of pancreatic cancer
$526,861Joo H Hwang · University Of Washington · R01 · FY2012 · CA
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
$526,795Alan Ashworth · University Of California, San Francisco · R01 · FY2019 · CA
Tech Core 2
$526,720Denis Wirtz · Johns Hopkins University · U54 · FY2024 · CA
Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
$526,651Xi Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Endoplasmic Reticulum-to-Mitochondria Calcium Transfer in Pancreatic Cancer Development, Metastasis, and Treatment
$526,598J. Kevin Kevin Foskett · University Of Pennsylvania · R01 · FY2025 · CA
Endoplasmic Reticulum-to-Mitochondria Calcium Transfer in Pancreatic Cancer Development, Metastasis, and Treatment
$526,598J. Kevin Kevin Foskett · University Of Pennsylvania · R01 · FY2021 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2025 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Chuan-Yuan Li · Duke University · R01 · FY2021 · CA
Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancers
$526,540John D Gordan · University Of California, San Francisco · R37 · FY2025 · CA
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$526,519Minah Kim · Columbia University Health Sciences · R37 · FY2025 · CA
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
$526,425Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA